CHPA pushes for DXM bill
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association "already has begun an initiative to seek reintroduction" of the Dextromethorphan Distribution Act of 2006 in the next session of Congress since the Senate did not address the legislation before Congress adjourned Dec. 9. The bill, which passed the House by voice vote Dec. 6, would allow FDA to limit the distribution of bulk ingredient DXM to people or entities registered with the agency, and would make it more difficult for teens to abuse the drug (1"The Tan Sheet" Dec. 11, 2006, p. 11). "We are committed to educating and empowering parents to take responsibility and action by informing their children of the dangers of abusing both Rx and OTC medicines," CHPA President Linda Suydam states in the association's executive newsletter Dec. 15...
The Consumer Healthcare Products Association "already has begun an initiative to seek reintroduction" of the Dextromethorphan Distribution Act of 2006 in the next session of Congress since the Senate did not address the legislation before Congress adjourned Dec. 9. The bill, which passed the House by voice vote Dec. 6, would allow FDA to limit the distribution of bulk ingredient DXM to people or entities registered with the agency, and would make it more difficult for teens to abuse the drug (1 (Also see "Dextromethorphan Bulk-Sale Limit Clears House, But Stalls In Senate" - Pink Sheet, 11 Dec, 2006.), p. 11). "We are committed to educating and empowering parents to take responsibility and action by informing their children of the dangers of abusing both Rx and OTC medicines," CHPA President Linda Suydam states in the association's executive newsletter Dec. 15.... |